Clinical Trials Browser

Phase 1/2 × INDUSTRY × Pharmaceutical Preparations × Clear all

NCT07431216 2026-02-24

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression

Phase 1/2 Not yet recruiting

Glioblastoma

NCT07364422 2026-01-23

To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Stomach Neoplasms

NCT01711398 2015-02-12

IP N02

Phase 1/2 Completed

Other solid neoplasm

All Solid Tumors

NCT00087854 2008-04-23

Study of Individualized Amonafide to Treat Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms